COVID-19 Impact on Global Non-Opioid Pain Treatment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Medical Cannabis Treatment
  • 1.4.3 Capsaicin-derived Treatment
  • 1.4.4 Menthol-containing Treatment
  • 1.4.5 Omega 3 fatty acid-containing Treatment
  • 1.4.6 Botulinum Toxins
• 1.5 Market by Application
  • 1.5.1 Global Non-Opioid Pain Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Orthopaedic and Musculoskeletal Pain
  • 1.5.3 Neuropathic Pain
  • 1.5.4 Cancer Pain
  • 1.5.5 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Non-Opioid Pain Treatment Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Non-Opioid Pain Treatment Industry
    • 1.6.1.1 Non-Opioid Pain Treatment Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Non-Opioid Pain Treatment Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Non-Opioid Pain Treatment Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Non-Opioid Pain Treatment Market Perspective (2015-2026)
• 2.2 Non-Opioid Pain Treatment Growth Trends by Regions
  • 2.2.1 Non-Opioid Pain Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Non-Opioid Pain Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Non-Opioid Pain Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Non-Opioid Pain Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Non-Opioid Pain Treatment Players by Market Size
  • 3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Non-Opioid Pain Treatment Market Concentration Ratio
  • 3.2.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2019
• 3.3 Non-Opioid Pain Treatment Key Players Head office and Area Served
• 3.4 Key Players Non-Opioid Pain Treatment Product Solution and Service
• 3.5 Date of Enter into Non-Opioid Pain Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2021-2026)

5 Non-Opioid Pain Treatment Breakdown Data by Application (2015-2026)

• 5.1 Global Non-Opioid Pain Treatment Market Size by Application (2015-2020)
• 5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Non-Opioid Pain Treatment Market Size (2015-2020)
• 6.2 Non-Opioid Pain Treatment Key Players in North America (2019-2020)
• 6.3 North America Non-Opioid Pain Treatment Market Size by Type (2015-2020)
• 6.4 North America Non-Opioid Pain Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Non-Opioid Pain Treatment Market Size (2015-2020)
• 7.2 Non-Opioid Pain Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Non-Opioid Pain Treatment Market Size by Type (2015-2020)
• 7.4 Europe Non-Opioid Pain Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Non-Opioid Pain Treatment Market Size (2015-2020)
• 8.2 Non-Opioid Pain Treatment Key Players in China (2019-2020)
• 8.3 China Non-Opioid Pain Treatment Market Size by Type (2015-2020)
• 8.4 China Non-Opioid Pain Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Non-Opioid Pain Treatment Market Size (2015-2020)
• 9.2 Non-Opioid Pain Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Non-Opioid Pain Treatment Market Size by Type (2015-2020)
• 9.4 Japan Non-Opioid Pain Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Non-Opioid Pain Treatment Market Size (2015-2020)
• 10.2 Non-Opioid Pain Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Non-Opioid Pain Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Non-Opioid Pain Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Non-Opioid Pain Treatment Market Size (2015-2020)
• 11.2 Non-Opioid Pain Treatment Key Players in India (2019-2020)
• 11.3 India Non-Opioid Pain Treatment Market Size by Type (2015-2020)
• 11.4 India Non-Opioid Pain Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Non-Opioid Pain Treatment Market Size (2015-2020)
• 12.2 Non-Opioid Pain Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Non-Opioid Pain Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Non-Opioid Pain Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Allergan PLC
  • 13.1.1 Allergan PLC Company Details
  • 13.1.2 Allergan PLC Business Overview and Its Total Revenue
  • 13.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction
  • 13.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2015-2020))
  • 13.1.5 Allergan PLC Recent Development
• 13.2 Canopy Growth
  • 13.2.1 Canopy Growth Company Details
  • 13.2.2 Canopy Growth Business Overview and Its Total Revenue
  • 13.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction
  • 13.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 13.2.5 Canopy Growth Recent Development
• 13.3 Medical Marijuana Inc.
  • 13.3.1 Medical Marijuana Inc. Company Details
  • 13.3.2 Medical Marijuana Inc. Business Overview and Its Total Revenue
  • 13.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction
  • 13.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 13.3.5 Medical Marijuana Inc. Recent Development
• 13.4 Panag Pharma Inc.
  • 13.4.1 Panag Pharma Inc. Company Details
  • 13.4.2 Panag Pharma Inc. Business Overview and Its Total Revenue
  • 13.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction
  • 13.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 13.4.5 Panag Pharma Inc. Recent Development
• 13.5 Tilray
  • 13.5.1 Tilray Company Details
  • 13.5.2 Tilray Business Overview and Its Total Revenue
  • 13.5.3 Tilray Non-Opioid Pain Treatment Introduction
  • 13.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 13.5.5 Tilray Recent Development
• 13.6 Aphria Inc.
  • 13.6.1 Aphria Inc. Company Details
  • 13.6.2 Aphria Inc. Business Overview and Its Total Revenue
  • 13.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction
  • 13.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 13.6.5 Aphria Inc. Recent Development
• 13.7 Bedrocan
  • 13.7.1 Bedrocan Company Details
  • 13.7.2 Bedrocan Business Overview and Its Total Revenue
  • 13.7.3 Bedrocan Non-Opioid Pain Treatment Introduction
  • 13.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 13.7.5 Bedrocan Recent Development
• 13.8 Cara Therapeutics
  • 13.8.1 Cara Therapeutics Company Details
  • 13.8.2 Cara Therapeutics Business Overview and Its Total Revenue
  • 13.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction
  • 13.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 13.8.5 Cara Therapeutics Recent Development
• 13.9 Centrexion Therapeutics
  • 13.9.1 Centrexion Therapeutics Company Details
  • 13.9.2 Centrexion Therapeutics Business Overview and Its Total Revenue
  • 13.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction
  • 13.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 13.9.5 Centrexion Therapeutics Recent Development
• 13.10 CHT Medical
  • 13.10.1 CHT Medical Company Details
  • 13.10.2 CHT Medical Business Overview and Its Total Revenue
  • 13.10.3 CHT Medical Non-Opioid Pain Treatment Introduction
  • 13.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 13.10.5 CHT Medical Recent Development
• 13.11 Cronos Group
  • 10.11.1 Cronos Group Company Details
  • 10.11.2 Cronos Group Business Overview and Its Total Revenue
  • 10.11.3 Cronos Group Non-Opioid Pain Treatment Introduction
  • 10.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 10.11.5 Cronos Group Recent Development
• 13.12 GW Pharmaceuticals
  • 10.12.1 GW Pharmaceuticals Company Details
  • 10.12.2 GW Pharmaceuticals Business Overview and Its Total Revenue
  • 10.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction
  • 10.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 10.12.5 GW Pharmaceuticals Recent Development
• 13.13 Medropharm Gmbh
  • 10.13.1 Medropharm Gmbh Company Details
  • 10.13.2 Medropharm Gmbh Business Overview and Its Total Revenue
  • 10.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction
  • 10.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 10.13.5 Medropharm Gmbh Recent Development
• 13.14 US Worldmeds LLC
  • 10.14.1 US Worldmeds LLC Company Details
  • 10.14.2 US Worldmeds LLC Business Overview and Its Total Revenue
  • 10.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction
  • 10.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  • 10.14.5 US Worldmeds LLC Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer